Advertisement

AAPS PharmSci

, Volume 6, Issue 1, pp 112–119 | Cite as

Encapsulation of water-insoluble drug by a cross-linking technique: Effect of process and formulation variables on encapsulation efficiency, particle size, and in vitro dissolution rate

  • Pralhad T. Tayade
  • Rajendrakumar D. Kale
Article

Abstract

Ibuprofen-gelatin micropellets were prepared by the cross-linking technique using formaldehyde. Spherical micropellets having an entrapment efficiency of 65% to 85% were obtained. The effect of core to coat ratio, speed of agitation, temperature, and volume of oil phase was studied with respect to entrapment efficiency, micropellet size, and surface characteristics. Fourier transform infrared spectroscopy and differential scanning calorimetric analysis confirmed the absence of any drug-polymer interaction. X-ray diffraction patterns showed that there is a decrease in crystallinity of the drug. The micromeritic properties of micropellets were found to be slightly changed by changing various processing parameters to give micropellets of good flow property. The in vitro release profile could be altered significantly by changing various processing parameters to give a controlled release of drug from the micropellets. The stability studies of the drug-loaded micropellets showed that the drug was stable at storage conditions of room temperature, 37°C, 25°/60% relative humidity (RH) and 45°/60% RH, for 12 weeks.

Keywords

ibuprofen micropellets gelatin micropellets 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goodman S, Gilman A. The Pharmacological Basis of Therapeutics. New York, NY: Macmillan Publishing Company, 1985.Google Scholar
  2. 2.
    Sellassie IG. Multiparticulate Oral Drug Delivery. New York, NY: Marcel Dekker Inc; 1994.CrossRefGoogle Scholar
  3. 3.
    Deasy PB. Microencapsulation and Related Drug Processes. New York, NY: Marcel Dekker Inc; 1984.Google Scholar
  4. 4.
    Kondo A. Microcapsule Processing and Technology. New York, NY: Marcel Dekker Inc; 1979.Google Scholar
  5. 5.
    Sjoergen J. Rate Control in Drug Therapy. Edinburgh, UK: Churchill Livingstone; 1985.Google Scholar
  6. 6.
    Tanaka N, Takino S, Utsumi I. A new oral gelatinized sustained release dosage form. J. Pharm Sci. 1962; 52: 664–667.CrossRefGoogle Scholar
  7. 7.
    Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y, Furuyama S. Characterization of polymorphs of tranilast anhydrate and tranilast monohydrate when crystallized by two solvent change spherical crystallization techniques. J Pharm Sci. 1991; 81: 472–478.CrossRefGoogle Scholar
  8. 8.
    Barkai A, Pathak V, Benita S. Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization. Drug Dev Ind Pharm. 1990; 16: 2057–2075.CrossRefGoogle Scholar
  9. 9.
    Bodmeier R, Chen H. Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen. J Control Release. 1989; 10: 167–175.CrossRefGoogle Scholar
  10. 10.
    Jones DS, Pearce KJ. Investigation of the effects of some process variables on, microencapsulation of propranolol HCl by solvent evaporation method. Int J Pharm. 1995; 118: 99–205.CrossRefGoogle Scholar
  11. 11.
    Sato T, Kanke M, Schroeder G, Deluca P. Porous biodegradable microspheres for controlled drug delivery. I: Assessment of processing conditions and solvent removal techniques. Pharm Res. 1988; 5: 21–30CrossRefPubMedGoogle Scholar
  12. 12.
    Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetic. Chem Pharm Bull (Tokyo). 1981; 29: 3363–3368.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2004

Authors and Affiliations

  1. 1.Department of PharmaceuticsBombay College of PharmacyMumbaiIndia

Personalised recommendations